NCT03215810
Nivolumab and Tumor Infiltrating Lymphocytes (TIL) in Advanced Non-Small Cell Lung Cancer treatment 1 completed NCT04699071
Trial of Lenvatinib Plus PembrolizumAb in Recurrent Gynecological Clear Cell Adenocarcinomas (LARA) treatment 2 recruiting NCT01730118
Ad/HER2/Neu Dendritic Cell Cancer Vaccine Testing treatment 1 completed NCT05273554
A Pilot Study to Assess Changes in Tumor Biology Following Second-line Treatment With Pembrolizumab Plus Lenvatinib in Patients With Advanced Pancreatic Ductal Adenocarcinoma treatment 1 active_not_recruiting NCT00688753
RAPTOR: RAD001 as Monotherapy in the Treatment of Advanced Papillary Renal Cell Tumors Program in Europe treatment 2 completed NCT01476553
Elimination of Peritoneal Tumor Cells With Extensive Peritoneal Lavage During Surgery in Patients With Gastric Cancer No drug interventions treatment Not Available terminated NCT02454647
Induction Chemotherapy, Chemoradiotherapy and Surgery in Locally Advanced Gastric Cancer Patients No drug interventions Not Available Not Available completed NCT01640847
MRI Guided High Intensity Focused Ultrasound (HIFU) and ThermoDox for Palliation of Painful Bone Metastases treatment 2 withdrawn NCT05574647
Imperial Prostate 7 - Prostate Assessment Using Comparative Interventions - Fast Mri and Image-fusion for Cancer No drug interventions diagnostic Not Available recruiting NCT00094445
Trial of Curcumin in Advanced Pancreatic Cancer treatment 2 completed NCT01646697
Slide Interpretation or Standard Surgical Pathology in Assessing Margin Status in Patients With Pancreatic Cancer Undergoing Surgery No drug interventions diagnostic Not Available completed NCT01784861
VEGFR/PDGFR Dual Kinase Inhibitor X-82 and Everolimus for Treating Patients With Pancreatic Neuroendocrine Tumors treatment 1 / 2 terminated NCT00430261
Phase II Trial of Sunitinib in BAC or Never-Smokers With Any Lung Adenocarcinoma treatment 2 completed NCT02130011
Dose-Guided Radiotherapy in Oesophageal Cancer: Managing the Real Dose No drug interventions treatment Not Available completed NCT02374411
Knowledge, Attitudes, and Practice of Surgeons Toward Nutrition Support in HIPEC Patients No drug interventions Not Available Not Available completed NCT00083278
Study of MDX-010 in Stage IV Breast Cancer treatment 2 completed NCT02741778
Minimally Invasive Sweet Esophagectomy for Patients With Siewert Type II Adenocarcinoma of the Esophagogastric Junction No drug interventions treatment Not Available unknown_status NCT02905578
A Phase 2 Trial of High-dose Ascorbate for Pancreatic Cancer (PACMAN 2.1) treatment 2 active_not_recruiting NCT02194556
Sequential and Maintenance Icotinib Plus Chemotherapy Versus Icotinib Maintenance After Chemotherapy in Advanced NSCLC treatment 4 unknown_status NCT03636685
Study of Anlotinib Plus Chemotherapy as the First-line Treatment in Patients With Advanced NSCLC treatment 1 / 2 unknown_status NCT02394652
The Potential for Metformin to Improve Tumor Oxygenation in Locally Advanced Cervix Cancer: A Phase II Randomized Trial treatment 2 completed NCT01249352
A Study of Chemoradiation Associated With Nimotuzumab as the Treatment of Locally Advanced Esophageal Cancer treatment 2 / 3 completed NCT00395252
Safety and Efficacy Therapy of Gemcitabine and Erbitux® to R0 or R1 Resected Pancreatic Cancer treatment 2 completed NCT01171300
Assessment of Response Before, During and After Neoadjuvant Chemoradiotherapy in Rectal Cancer Patients No drug interventions other Not Available active_not_recruiting NCT00102700
ARQ 501 in Combination With Gemcitabine in Subjects With Pancreatic Cancer treatment 2 completed NCT01946100
Treatment of Multifocal Lung Adenocarcinoma No drug interventions treatment Not Available active_not_recruiting NCT04401059
Synergistic Effect of Elemene Plus TKIs Compared With TKIs in EGFR-mutated Advanced NSCLC：Prospective Study treatment 4 recruiting NCT01677559
Combining MLN8237 With Nab-Paclitaxel in Patients With Advanced Solid Malignancies treatment 1 completed NCT00183859
Clinical and Pharmacokinetic Trial of Intra-Abdominal Irinotecan treatment 1 completed NCT04374175
SERum-bank for PANcreatic Cancer No drug interventions Not Available Not Available recruiting NCT00140075
Adjuvant Epirubicin/Cytoxan Followed By A Taxane VS. Epirubicin/Taxane As Treatment For Node-Positive Breast Cancer treatment 3 completed NCT00051675
Phase I Study of a Monoclonal Antibody for Treatment of Advanced Adenocarcinomas treatment 1 completed NCT04644770
A Study of JNJ-69086420, an Actinium-225-Labeled Antibody Targeting Human Kallikrein-2 (hK2) for Advanced Prostate Cancer treatment 1 recruiting NCT02428270
A Study of GSK2256098 and Trametinib in Advanced Pancreatic Cancer treatment 2 completed NCT01995942
Molecular, Pathologic and MRI Investigation of the Prognostic and Redictive Importance of Extramural Venous Invasion in Rectal Cancer (MARVEL) Trial No drug interventions Not Available Not Available unknown_status NCT01077999
Chemoradiation and Panitumumab for Esophageal Cancer treatment 2 completed NCT02151149
Safety and Efficacy Study of Abraxane in Combination With Carboplatin to Treat Advanced NSCL Cancer in the Elderly treatment 4 completed NCT02980536
cSMART Liquid Biopsy and Dynamic Monitor of NSCLC Patients in Inner-Mongolia China No drug interventions Not Available Not Available unknown_status NCT05065736
Using a PET Imaging Agent, 18F-Clofarabine (CFA), to Measure Deoxycytidine Kinase Activity in Metastatic Cancer diagnostic 0 recruiting NCT05678218
Preoperative Evaluation of Lymph Nodes of Cholangiocarcinoma No drug interventions Not Available Not Available recruiting NCT00911118
Dose Escalation Study Using Ultra-Hypofractionated, Image-Guided, Intensity-Modulated Radiotherapy in Prostate Cancer No drug interventions treatment 1 active_not_recruiting NCT00201734
Capecitabine, Carboplatin and Weekly Paclitaxel for Patients With Solid Tumors and Adenocarcinoma of Unknown Primary treatment 1 / 2 terminated NCT00495924
Perioperative Cancer Cell Dissemination and Systemic Immune Suppression in Resectable Ductal Pancreatic Adenocarcinoma No drug interventions Not Available Not Available completed NCT03462524
Neoadjuvant Therapy for Esophageal Cancer and Cardiopulmonary Physiology No drug interventions Not Available Not Available completed NCT02387216
A Study of MM-121 in Combination With Chemotherapy Versus Chemotherapy Alone in Heregulin Positive NSCLC treatment 2 terminated NCT05511116
Neoadjuvant Treatment of Resectable or Locally Advanced Borderline Pancreatic Adenocarcinoma: Reproducibility of Tumor Measurement in CT VS MRI No drug interventions Not Available Not Available active_not_recruiting NCT02133196
T Cell Receptor Immunotherapy for Patients With Metastatic Non-Small Cell Lung Cancer treatment 2 recruiting NCT00443196
Testing Drug Sensitivity of Ovarian, Fallopian and Primary Peritoneal Adenocarcinomas No drug interventions treatment 2 / 3 completed NCT03695835
A Data Collection Study for Patients With Adenocarcinoma Treated With the MyVaccx Immunotherapy Regimen. Not Available Not Available completed NCT05337163
A Multicenter Clinical Trial of Sputum DNA Testing for Lung Cancer in China No drug interventions Not Available Not Available completed NCT04227886
Study on Predictive Biomarkers of Neoadjuvant Chemoradiotherapy for Rectal Cancer Not Available Not Available unknown_status NCT02082886
HIPEC For Peritoneal Surface Malignancies Including Carcinomatosis or Sarcomatosis - Data Registry No drug interventions Not Available Not Available completed NCT01295086
Taxotere®, Eloxatin® and Xeloda® (TEX) in Combination With Herceptin® as Treatment for HER2 Positive Non-resectable Cancer treatment Not Available completed NCT03578939
Next Generation Sequencing of Tumor Cells in Locally Advanced Pancreatic Adenocarcinoma No drug interventions Not Available Not Available completed NCT01253525
Study of Weekly Paclitaxel With Ramucirumab in Participants With Advanced Gastric Adenocarcinomas treatment 1 completed NCT05922930
Study of TROP2 CAR Engineered IL15-transduced Cord Blood-derived NK Cells Delivered Intraperitoneally for the Management of Platinum Resistant Ovarian Cancer, Mesonephric-like Adenocarcinoma, and Pancreatic Cancer treatment 1 / 2 recruiting NCT01020630
Sunitinib in Patients With Advanced Gastric Cancer and Treated With FOLFIRI treatment 2 completed NCT02653248
SBRT for Organ Confined Prostate Cancer No drug interventions treatment 1 completed NCT00548548
A Study of Bevacizumab in Combination With Capecitabine and Cisplatin as First-line Therapy in Patients With Advanced Gastric Cancer treatment 3 completed NCT00436657
Continuous Hyperthermic Peritoneal Perfusion (CHPP) With Cisplatin for Children With Peritoneal Cancer treatment 1 completed NCT02785757
Cancer-related Thromboembolic Disease No drug interventions other Not Available unknown_status NCT00923026
Follow Up Protocol for Subjects Previously Enrolled on NCI Surgery Branch Studies No drug interventions Not Available Not Available enrolling_by_invitation NCT01824966
Signet Ring Cell Carcinoma in Esophageal Adenocarcinoma No drug interventions Not Available Not Available completed NCT01363466
Evaluation of Hysterectomy After Chemoradiation Therapy for Stage IB2/II Cervical Cancer No drug interventions treatment 3 terminated NCT04400474
Trial of Cabozantinib Plus Atezolizumab in Advanced and Progressive Neoplasms of the Endocrine System. The CABATEN Study treatment 2 active_not_recruiting NCT00201331
Prospective Phase II Randomized Trial of Postoperative Adjuvant Chemotherapy in Patients With High Risk Colon Cancer treatment 2 unknown_status NCT06046131
Clinical, Genetic and Environmental Determinants of Prostate Cancer Progression. No drug interventions other Not Available recruiting NCT05241873
(Concerto) Study of BLU-451 in Advanced Cancers With EGFR Exon 20 Insertion Mutations treatment 1 / 2 active_not_recruiting NCT02498860
Efficacy and Safety of Adjuvant Pemetrexed Plus Cisplatin for Adenocarcinoma of Lung treatment 2 completed NCT04862780
(SYMPHONY) Phase 1/2 Study Targeting EGFR Resistance Mechanisms in NSCLC treatment 1 / 2 active_not_recruiting NCT04660929
CAR-macrophages for the Treatment of HER2 Overexpressing Solid Tumors treatment 1 active_not_recruiting NCT00116389
Trial of Talabostat and Gemcitabine in Patients With Stage IV Adenocarcinoma of the Pancreas treatment 2 terminated NCT00102544
Use of Tracking Devices to Locate Abnormalities During Invasive Procedures No drug interventions device_feasibility Not Available enrolling_by_invitation NCT01032044
CLE for Assessment of Neoplasia After Mucosal Ablation or Resection of Gastrointestinal Neoplasia No drug interventions diagnostic Not Available completed NCT02125240
Icotinib Versus Placebo as Adjuvant Therapy in EGFR-mutant Lung Adenocarcinoma treatment 3 unknown_status NCT02875340
A Study of VAL401 in the Treatment of Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer treatment 2 completed NCT03840967
A Study Evaluating Safety and Efficacy of Niraparib in Patients With Previously Treated Metastatic Esophageal/Gastroesophageal Junction/Proximal Gastric Adenocarcinoma treatment 2 terminated NCT04222972
A Study of Pralsetinib Versus Standard of Care for First-Line Treatment of Advanced Non-Small Cell Lung Cancer (NSCLC) treatment 3 active_not_recruiting NCT01433172
Combination Immunotherapy of GM.CD40L Vaccine With CCL21 in Lung Cancer No drug interventions treatment 1 / 2 completed NCT05161572
Perioperative Chemoimmunotherapy With/Without Preoperative Chemoradiation for Locally Advanced Gastric Cancer treatment 2 recruiting NCT02926768
Phase I/II Study of CK-101 in NSCLC Patients and Other Advanced Solid Tumors treatment 1 completed NCT06241469
Efficacy and Safety of Sintilimab Combined With Nab-paclitaxel and Tegio (aTS) as First-line Treatment of Unresectable Locally Advanced, Recurrent or Metastatic Adenocarcinoma of Gastric and Gastroesophageal Junction，a Phase II Clinical Study treatment 2 not_yet_recruiting NCT02788669
LRP1 and Colon Cancer No drug interventions Not Available Not Available unknown_status NCT02204046
Biodistribution Study With 186 Re-labelled Humanised Monoclonal Antibody BIWA 4 in Patients With Adenocarcinoma of the Breast treatment 1 completed NCT01301612
Study of Nimotuzumab, Radiation Therapy and Cisplatin Versus Radiation Therapy and Cisplatin for Treatment of Stage IB e IVA UCC(CORUS) treatment 2 withdrawn NCT03013010
PREACT Study: Locally Advanced Gastric Cancer, Chemoradiotherapy vs. Chemotherapy Followed by D2 Surgery and Adjuvant Chemotherapy treatment 3 unknown_status NCT06090214
Liquid Biopsy for the Diagnosis of Intestinal-type Adenocarcinoma of the Ethmoid (BLADE) No drug interventions diagnostic Not Available not_yet_recruiting NCT02795650
Personalised Therapy for Metastatic ADPC Determined by Genetic Testing and Avatar Model Generation No drug interventions treatment 2 unknown_status NCT00949650
BIBW 2992 (Afatinib) Versus Chemotherapy as First Line Treatment in NSCLC With EGFR Mutation treatment 3 completed NCT01135823
Symptom Assessment With Patient Surveys No drug interventions Not Available Not Available completed NCT00201838
Etanercept and Gemcitabine in Patients With Advanced, Chemotherapy Naive Pancreatic Adenocarcinoma treatment 1 / 2 completed NCT00751543
The Character of Perfusion Parameters Derived From MDCT Between Adenocarcinoma and Squamous Cell Carcinoma of Lung in the Treatment Course of Radiation Therapy No drug interventions treatment Not Available unknown_status NCT04667403
Telemedicine in the Management of Pain in Patients With Advanced or Metastatic Pancreatic Cancer No drug interventions supportive_care Not Available unknown_status NCT00191503
Gemcitabine and Pemetrexed in Primary Unknown Adenocarcinoma treatment 2 completed NCT02943603
A Study of Perioperative mFOLFOX6 Plus Pembrolizumab in Patients With Potentially Resectable Adenocarcinoma of the Gastroesophageal Junction (GEJ) and Stomach treatment 2 withdrawn NCT02370303
A Study to Isolate and Test Circulating Tumor Cells Using the ClearCell® FX EP+ System No drug interventions Not Available Not Available completed NCT02410603
Isolating and Testing Circulating Tumor DNA and Soluble Immune Markers During the Course of Treatment for Lung Cancer No drug interventions Not Available Not Available completed NCT04263090
Rigosertib Plus Nivolumab for KRAS+ NSCLC Patients Who Progressed on First-Line Treatment treatment 1 / 2 completed NCT00719264
Safety and Efficacy of Bevacizumab Plus RAD001 Versus Interferon Alfa-2a and Bevacizumab for the First-line Treatment in Adult Patients With Kidney Cancer treatment 2 completed NCT05581121
PARa-aOrtic LymphAdenectomy in Locally Advanced Cervical Cancer No drug interventions treatment 3 recruiting NCT00600821
A Study Of AG-013736 (Axitinib) Or Bevacizumab (Avastin) In Combination With Paclitaxel And Carboplatin In Patients With Advanced Lung Cancer. treatment 2 completed NCT01579721
Prospective Randomized Study of SILS Versus CLS for Rectal Cancer No drug interventions treatment 4 completed NCT01502202
Intercalated Administration of PamCis With Gefitinib or Placebo as First Line Lung Adenocarcinoma in Never Smokers treatment 2 unknown_status NCT00795184
Detection Of Neoplastic Tissue in Barrett's Esophagus With In vivO Probe-based Confocal Endomicroscopy No drug interventions diagnostic Not Available completed NCT03000179
Safety and Efficacy of Avelumab in Small Intestinal Adenocarcinoma treatment 2 terminated NCT04028479
The Registry of Oncology Outcomes Associated With Testing and Treatment No drug interventions Not Available Not Available recruiting NCT00259987
Effects Of Lapatinib (GW572016) In Patients With Relapsed Adenocarcinoma Of The Esophagus treatment 2 completed NCT01130233
Randomized Trial on Robotic Assisted Resection for Rectal Cancer No drug interventions treatment 3 unknown_status NCT03415854
Paclitaxel Protein Bound Plus Cisplatin Plus Gemcitabine and Paricalcitol for Pancreatic Adenocarcinoma (NABPLAGEMD) treatment 2 completed NCT02335151
CTC Pancreatic Adenocarcinoma treatment 4 completed NCT01952951
Preoperative Chemoradiation Followed by Chemotherapy for Locally Advanced Rectal Cancer treatment 2 unknown_status NCT00106353
Study Evaluating Biomarkers In Relapsed/Refractory Pediatric Solid Tumors treatment 1 / 2 completed NCT00918853
Prospective Evaluation of the Resection Margins and the Ganglionic Status Using a Quality Standard Resection for Adenocarcinoma of the Head of the Pancreas No drug interventions treatment Not Available completed NCT02487277
PEGPH20, Gemicitabine and Nab-Paclitaxel for Pancreatic Ductal Adenocarcinoma treatment 2 terminated NCT00230347
Evaluation of Stereotactic Radiosurgery For Liver Malignancies No drug interventions treatment 1 completed NCT00298545
Effect of Vitamin D and Calcium on Genes in the Colon prevention 1 completed NCT01393483
Evaluate Mesothelin as a Biomarker for the Clinical Management of Esophageal Adenocarcinoma (EAC) No drug interventions Not Available Not Available active_not_recruiting NCT02973828
PRIMER: Development of Daily Online Magnetic Resonance Imaging for Magnetic Resonance Image Guided Radiotherapy No drug interventions Not Available Not Available recruiting NCT01441128
-02341066 and PF-00299804 for Advanced Non-Small Cell Lung Cancer treatment 1 terminated NCT01121393
BIBW 2992 (Afatinib) vs Gemcitabine-cisplatin in 1st Line Non-small Cell Lung Cancer (NSCLC) treatment 3 completed NCT01009593
Efficacy and Tolerability of ABT-869 Versus Sorafenib in Advanced Hepatocellular Carcinoma (HCC) treatment 3 terminated NCT04543071
Chemo4METPANC Combination Chemokine Inhibitor, Immunotherapy, and Chemotherapy in Pancreatic Adenocarcinoma treatment 2 recruiting NCT00127478
A Long Term Safety Study With Atrasentan treatment 2 / 3 completed NCT02795988
A Study of IMU-131(HER-Vaxx) and Chemotherapy Compared to Chemotherapy Only in Patients With HER2 Positive Advanced Gastric Cancer treatment 1 / 2 active_not_recruiting NCT00672009
A Study of Ixabepilone Before Surgery for High-Risk Localized Prostate Cancer treatment 2 terminated NCT01365156
Extraperitoneal Para-aortic Lymph Node Dissection (EPLND) for Cervix No drug interventions treatment 3 completed NCT03037385
Phase 1/2 Study of the Highly-selective RET Inhibitor, Pralsetinib (BLU-667), in Participants With Thyroid Cancer, Non-Small Cell Lung Cancer, and Other Advanced Solid Tumors treatment 1 / 2 completed NCT01556815
Sorafenib Combined With Transarterial Chemoembolization in Treating HBV-infected Patients With Intermediate Hepatocellular Carcinoma No drug interventions treatment 2 unknown_status NCT01962532
A Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of JNJ-42756493 in Patients With Advanced or Refractory Solid Tumors or Lymphoma treatment 1 completed NCT06121700
Radiotherapy + Chemoimmunotherapy Followed by Surgery in Patients With Limited Metastatic Gastric or GEJ Cancer treatment 2 recruiting NCT02341170
HS-PCI in Locally Advanced Adenocarcinoma of the Lung No drug interventions treatment Not Available withdrawn NCT02183870
EUCROSS: European Trial on Crizotinib in ROS1 Translocated Lung Cancer treatment 2 completed NCT00892242
Perioperative Treatment With Zoledronic Acid in Patients With Resectable Pancreas Cancer treatment 1 terminated NCT02404506
Eribulin as 1st Line Treatment in Elderly Patients With Advanced Breast Cancer treatment 2 terminated NCT00895349
Impact of Positron Emission Tomography (PET) Imaging in Women With Locally Advanced Cervical Cancer (PET LACE Trial) No drug interventions diagnostic Not Available completed NCT01037049
Optimum Timing for Surgery After Pre-operative Radiotherapy 6 vs 12 Weeks No drug interventions other 2 unknown_status NCT01125449
Study of High Dose Intravenous (IV) Ascorbic Acid in Measurable Solid Tumor Disease treatment 2 suspended NCT00247936
Combined Thoracoscopic and Laparoscopic Esophagectomy vs. Hand-assisted Transhiatal Esophagectomy: A Prospective Trial. No drug interventions treatment Not Available withdrawn NCT00127036
Trial for Microarray Analysis of Colon Cancer Outcome-A (MACCO-A) treatment 2 terminated NCT00377936
EndoTAG-1 / Gemcitabine Combination Therapy to Treat Locally Advanced and/or Metastatic Adenocarcinoma of the Pancreas treatment 2 completed NCT00088413
PANVAC-V and PANVAC-F Vaccines Plus Sargramostim to Treat Advanced Cancer treatment 1 / 2 completed NCT02347618
Pilot Study of Short-Course Preoperative Stereotactic Body Radiation Therapy for Resectable Pancreatic Cancer No drug interventions treatment Not Available completed NCT02292641
Beyond TME Origins No drug interventions treatment Not Available recruiting NCT01519817
Cancer Vaccine Targeting Brachyury Protein in Tumors treatment 1 completed NCT01077817
Observational Study of Incidence Rates of Esophageal Cancer in Women Taking Medications for the Prevention or Treatment of Osteoporosis (MK-0217A-352) Not Available Not Available completed NCT01665417
Icotinib as First-line and Maintenance Treatment in EGFR Mutated Patients With Lung Adenocarcinoma treatment 4 unknown_status NCT01051934
A Phase I Trial of SS1 (dsFv) PE38 With Paclitaxel, Carboplatin, and Bevacizumab in Subjects With Unresectable Non-Small Cell Lung Adenocarcinoma treatment 1 completed NCT06405035
Dissecting the Role of MIcrobioMe in gastroEsophageal Tumor: a multIdisCiplinary Longitudinal Study No drug interventions Not Available Not Available recruiting NCT02664935
National Lung Matrix Trial: Multi-drug Phase II Trial in Non-Small Cell Lung Cancer treatment 2 active_not_recruiting NCT01161186
Nab-paclitaxel (Abraxane), Gemcitabine, and Capecitabine (Xeloda) for Pancreatic Adenocarcinoma treatment 1 completed NCT00137839
Erlotinib in Women With Previously Untreated Adenocarcinoma of the Lung treatment 2 completed NCT01206530
FOLFOX/Bevacizumab/Hydroxychloroquine (HCQ) in Colorectal Cancer treatment 1 / 2 completed NCT00661830
Gemcitabine and Sorafenib in Advanced Biliary Tract Cancer (GEMSO) treatment 2 completed NCT03997448
Abemaciclib and Pembrolizumab in Locally Advanced Unresectable or Metastatic Gastroesophageal Adenocarcinoma: Big Ten Cancer Research Consortium BTCRC-GI18-149 treatment 2 terminated NCT05935748
Ph2 Study NKT2152 With Palbociclib & Sasanlimab in Subjects With Advanced Clear Cell Renal Cell Carcinoma (ccRcc) treatment 2 recruiting NCT00321048
Spect Analysis of Cardiac Perfusion Changes After Whole Breast/Chest Wall Radiation Therapy With ABC No drug interventions treatment Not Available completed NCT02103257
Sequential Icotinib Plus Chemotherapy Versus Icotinib Alone as First-line Treatment in Stage IIIB/IV Lung Adenocarcinoma treatment 4 unknown_status NCT05892926
HER2-positive Locally Advanced/Metastatic Gastric and/or Gastroesophageal Junction (GEJ) Adenocarcinoma in Russia No drug interventions Not Available Not Available recruiting NCT03591666
A Study of Anlotinib in Recurrent/Metastatic Head and Neck Adenocarcinomas treatment 2 unknown_status NCT02005965
Low Rectal Cancer Study (MERCURY II) No drug interventions Not Available Not Available unknown_status NCT01778920
Pilot and Feasibility Study of the Imaging Potential of EC17: Intraoperative Folate-fluorescein Conjugate (EC17) Lung Cancer (CA) No drug interventions diagnostic 1 completed NCT01148082
School Response to Families Who Have Children With Cancer No drug interventions Not Available Not Available withdrawn NCT00054873
Tezacitabine With or Without 5-Fluorouracil (5-FU) for Advanced Esophageal Cancer or Gastric Cancer treatment 2 completed NCT04069273
Novel SEQUEnced Immunotherapy With Anti-angiogenesis and Chemotherapy in Advanced gastroesophageaL Adenocarcinoma treatment 2 recruiting NCT03535727
A Study of Gemcitabine, Nab-paclitaxel, Capecitabine, Cisplatin, and Irinotecan in Metastatic Pancreatic Cancer treatment 1 / 2 completed NCT06337760
YOUNg Adults With Gastro-inteSTinal (GI) and nEuroendocrine canceRs. No drug interventions Not Available Not Available recruiting NCT02473094
Neoadjuvant Metformin in Association to Chemoradiotherapy for Locally Advanced Rectal Cancer treatment 2 terminated NCT00507091
Phase I Irinotecan, 5-Fluorouracil and Leucovorin Combination treatment 1 completed NCT00368329
Phase I Dose Escalation of Stereotactic Radiosurgical Boost for Locally Advanced Esophageal Cancer treatment 1 terminated NCT02213289
PANGEA-IMBBP: Personalized Antibodies for Gastro-Esophageal Adenocarcinoma - A 1st Pilot Metastatic Trial of Biologics Beyond Progression treatment 2 completed NCT00129844
Study of Motexafin Gadolinium (MGd) for Second Line Treatment of Non-Small-Cell Lung Cancer treatment 2 completed NCT01761240
Dose Escalation Study MORAb-066 Targeting Tissue Factor (TF)-Expressing Malignancies Including Breast, Pancreatic, Colorectal, NSCLC treatment 1 completed NCT03488667
Perioperative mFOLFOX Plus Pembrolizumab in Gastroesophageal Junction (GEJ) and Stomach Adenocarcinoma treatment 2 active_not_recruiting NCT06358001
EchoTip AcuCore Post-Market Clinical Study No drug interventions Not Available Not Available recruiting NCT00940069
TS Gene Polymorphism Predicts Effect in Patients With Advanced Lung Cancer treatment 2 completed NCT00800969
Prospective Evaluation of the Preoperative Lymph Node Staging in Patients With Cancer of the Esophagogastric Junction and Stomach No drug interventions diagnostic 2 withdrawn NCT01182246
AXP107-11 in Combination With Standard Gemcitabine (Gemzar® ) Therapy for Treatment in Patients With Pancreatic Cancer treatment 1 / 2 unknown_status NCT04361708
Safety of Combining Irinotecan With 5-FU, Leucovorin/Folinic Acid, Oxaliplatin, and Docetaxel Chemotherapies treatment 1 recruiting NCT05153408
(HARMONY) Study of BLU-701 in EGFR-mutant NSCLC treatment 1 terminated NCT01383538
FOLFIRINOX Plus IPI-926 for Advanced Pancreatic Adenocarcinoma treatment 1 completed NCT01365143
Prospective Randomized Trial Comparing Robotic Versus Open Radical Prostatectomy No drug interventions treatment 4 terminated NCT06128343
Anatomical-Clinical Base of Adenocarcinoma Pancreatic No drug interventions Not Available Not Available recruiting NCT00632203
Study of Maintenance Temozolomide Versus Observation in Stable or Responding Stage III/IV Non-Small Cell Lung Cancer Patients (Study P05146) treatment 2 terminated NCT01930864
Metformin Plus Irinotecan for Refractory Colorectal Cancer treatment 2 unknown_status NCT05325164
Methadone for 'Adenocarcinopathic' Pain Treatment treatment 3 withdrawn NCT00507702
Identification of Key Blood Molecular Markers for Immunotherapy No drug interventions Not Available Not Available terminated NCT00917384
Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Participants With Gastric Cancer and Adenocarcinoma treatment 3 completed NCT02426879
Esophagectomy for Patients With Esophageal Cancer and Cervical Lymph Node Metastases No drug interventions treatment Not Available completed